Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203464
Max Phase: Preclinical
Molecular Formula: C49H61N7O7
Molecular Weight: 860.07
Associated Items:
ID: ALA5203464
Max Phase: Preclinical
Molecular Formula: C49H61N7O7
Molecular Weight: 860.07
Associated Items:
Canonical SMILES: CCn1c2ccccc2c2cc(-c3nc(-c4ccc(N5CCN(C)CC5)cc4)c(-c4ccc(N5CCN(C)CC5)cc4)n3CCOCCO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc21
Standard InChI: InChI=1S/C49H61N7O7/c1-4-55-40-8-6-5-7-38(40)39-31-35(13-18-41(39)55)48-50-43(33-9-14-36(15-10-33)53-23-19-51(2)20-24-53)44(34-11-16-37(17-12-34)54-25-21-52(3)22-26-54)56(48)27-28-61-29-30-62-49-47(60)46(59)45(58)42(32-57)63-49/h5-18,31,42,45-47,49,57-60H,4,19-30,32H2,1-3H3/t42-,45-,46+,47-,49-/m1/s1
Standard InChI Key: VFOINVLTYDERDW-AUZSFSLZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 860.07 | Molecular Weight (Monoisotopic): 859.4632 | AlogP: 4.35 | #Rotatable Bonds: 14 |
Polar Surface Area: 144.32 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.21 | CX Basic pKa: 8.14 | CX LogP: 4.80 | CX LogD: 3.66 |
Aromatic Rings: 6 | Heavy Atoms: 63 | QED Weighted: 0.12 | Np Likeness Score: -0.24 |
1. Li ML, Yuan JM, Yuan H, Wu BH, Huang SL, Li QJ, Ou TM, Wang HG, Tan JH, Li D, Chen SB, Huang ZS.. (2022) Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective c-MYC Transcription Repressors Targeting the Promoter G-Quadruplex., 65 (19.0): [PMID:36121464] [10.1021/acs.jmedchem.2c00467] |
Source(1):